Nomura Holdings
HRMY icon

Nomura Holdings’s Harmony Biosciences HRMY Stock Holding History

Nomura Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,000
Closed -$579K – 2017
2025
Q3 		$579K Buy
+21,000
New +$723K ﹤0.01% 1565

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Nomura Holdings's HRMY Position: Q1 2026 in Review

Nomura Holdings increased its Harmony Biosciences (HRMY) stake by 2.1% in Q1 2026, buying an estimated $358K and bringing the position to 520,947 shares worth $14.6M. The position accounts for 0.04% of the portfolio, ranked #332.

Nomura Holdings first reported a position in HRMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $19.1M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Nomura Holdings held 520,947 shares of Harmony Biosciences worth $14.6M as of Q1 2026.
  • Nomura Holdings bought 10,923 Harmony Biosciences shares in Q1 2026, an estimated $358K.
  • Harmony Biosciences made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #332 holding.
  • Nomura Holdings first reported a position in Harmony Biosciences in Q1 2024 and has held it in 9 quarters since.
  • Nomura Holdings's Harmony Biosciences position peaked at $19.1M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.